Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Category list : Anti-dyskinesia agents

Sort by: Newest first Oldest first A-Z Z-A

Safinamide recommended for approval as Parkinson’s disease therapy Subscription

19 JAN 2015 9:47 By Janna Lawrence

A new medicine that allows Parkinson’s disease patients to spend more of the day symptom-free has been recommended for approval in Europe.

Hot Topics

See More Topics

Most Popular

Most Commented

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.

Tweets by @PJOnline_News

Join

Latest

Evaluation of the Royal Cornwall Hospitals NHS Trust community pharmacy transfer of care around medicines service

Misuse of prescription and over-the-counter drugs to obtain illicit highs: how pharmacists can prevent abuse

Pharmacist contributions to consultant-led post-take ward rounds: a service evaluation

Community pharmacist-led influenza vaccination: a service evaluation

Evaluation of a pharmacist-led virtual thiopurine clinic

Evaluating pharmacist interventions using the Simpler tool in Malaysian patients with type 2 diabetes

Latest

How to make the most of 2021

'The menopause can be overwhelming' – a day in the life of a women’s health pharmacist

Dilemma: when a line manager takes credit for your work

Unekwuojo Agada

Nabila Chaudhri

Mairead Conlon

Latest on the RPS

Oral poliomyelitis vaccine, 1960s

RPS backs changes to interval between COVID-19 vaccination doses

RPS launches 180-year anniversary celebrations with a new online history resource

Free access to pharmacy journals under five-year deal with Oxford University Press

Pharmacists can take the lead in public reassurance on COVID-19 vaccines, RPS says

Give provisionally registered pharmacists all the support you can, RPS urges employers

Category list : Anti-dyskinesia agents

Safinamide recommended for approval as Parkinson’s disease therapy Subscription

Top Stories

Hot Topics

Most Popular

Most Commented

Newsletter Sign-up

Information

Services

Contact

Publications

Partners